Related Experiment Videos
Expression and regulation of complement C1q by human THP-1-derived macrophages
1Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver, Canada. dgwalker@altavista.net
Insights
This study investigated C1q complement protein production in human THP-1 cells. Interferon-gamma and certain anti-inflammatory drugs significantly boosted C1q, while others inhibited it, offering insights into immune regulation.
Area of Science:
- Immunology
- Molecular Biology
Background:
- The complement system, particularly C1q, plays a crucial role in innate and adaptive immunity.
- Human monocytic THP-1 cells serve as a valuable model for studying monocyte/macrophage and microglial functions.
- Understanding C1q regulation is vital for developing therapeutic strategies targeting inflammatory and autoimmune diseases.
Purpose of the Study:
- To investigate the regulatory mechanisms of C1q expression in THP-1 cells.
- To identify pharmacological agents that modulate C1q production in a human monocyte/macrophage model.
Main Methods:
- THP-1 cells were differentiated into macrophage-like cells.
- Cells were treated with various immune modulators including interferon-gamma (IFN-gamma), interleukin-6 (IL-6), and lipopolysaccharide (LPS).
- The effects of anti-inflammatory steroids (dexamethasone, prednisone) and other pharmacological agents (tacrine, indomethacin, cimetidine, propentofylline) on C1q secretion were assessed.
Main Results:
- IFN-gamma, IL-6, LPS, dexamethasone, and prednisone significantly stimulated C1q production.
- Phorbol myristate acetate inhibited C1q expression.
- Tacrine demonstrated inhibitory activity on C1q secretion in IFN-gamma-stimulated cells, whereas indomethacin, cimetidine, and propentofylline did not.
Conclusions:
- THP-1 cells effectively model C1q regulation in human macrophages.
- Specific immune modulators and anti-inflammatory agents differentially regulate C1q production.
- Tacrine emerges as a potential inhibitor of C1q secretion in inflammatory contexts.
Abstract:
The regulation of C1q expression was examined in the human monocytic cell line THP-1. Since these cells can be differentiated into cells with macrophage properties and induced to express C1q, they were used as models for mature human monocyte/macrophages and indirectly microglia. Interferon-gamma (IFN-gamma) and the anti-inflammatory steroid agents dexamethasone and prednisone were powerful stimulators of C1q production, alone or in combination. Interleukin-6 (IL-6) and lipopolysaccharide (LPS) also had significant stimulatory activity. Phorbol myristate acetate, a protein kinase C activator, reduced C1q expression. Four additional classes of pharmacological agents were tested for their effect on C1q secretion. Tacrine, but not indomethacin, cimetidine, or propentofylline, showed activity in inhibiting C1q secretion by IFN-gamma treated THP-1-derived macrophages.